Maxillary Canine Retraction Assisted With Micro-osteoperforations Versus Injectable Platelet Rich Fibrin

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

PHASE2

Total Enrollment

18 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-12-31

Study Completion Date

2024-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The present clinical comparative study will be undertaken for assessment of two different modalities of maxillary canine retraction assisted with microosteoperforations versus injectable platelet rich fibrin.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Assessment of Maxillary Canine Retraction Using Self-ligating Brackets System Assisted With Micro-osteoperforations

NCT05595174

Accerleration of Tooth Movement

ENROLLING_BY_INVITATION NA

Evaluation of Two Approaches of Micro-osteoperforations (MOPs) During Orthodontic Canine Retraction

NCT04868721

Bimaxillary Protrusion Angle Class II, Division 1 Dental Malocclusions

COMPLETED NA

Assessment of the Efficacy of Microosteoperforations Versus Injectable Platelet-rich Fibrin During Orthodontic Leveling and Alignment of Mandibular Incisors

NCT06498609

Effect of Platelet Rich Fibrin Versus Microosteoperforation Compaed to Control Group Toothmovement

ENROLLING_BY_INVITATION NA

Evaluation of Leveling and Alignment of Maxillary Anterior Teeth Assisted With MOPs :A Comparative Clinical Study

NCT05605652

Crowding of Anterior Maxillary Teeth

UNKNOWN NA

Evaluation of Piezocision Versus Injectable Platelet-rich Fibrin During Orthodontic Canine Retraction Orthodontic Canine Retraction: A Comparative Clinical Study

NCT07239024

Effect of Piezocision and Injectable Platelets Rich Fibrin on Tooth Movement

ENROLLING_BY_INVITATION PHASE1

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Group I: will include 9 patients who willreceive MOPs with maxillary canine retraction that will be performed on intervention sides according to a standardized protocol.

▪ Group II: will include 9 patients receive i-PRF that will be performed on intervention sides according to a standardized protocol.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Effects of; Movement of Teeth Assiste Wit MOPS and I-prf

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

FACTORIAL

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group MOPs

Group MOPs : will include 9 patients who willreceive MOPs with maxillary canine retraction that will be performed on intervention sides according to a standardized protocol.

Group Type EXPERIMENTAL

injectable platelet rich fibrin versus microosteoperforation

Intervention Type COMBINATION_PRODUCT

injectable platelet rich fibrin which is second product of blood versus microosteoperforation which is surgical procedure

Group IMOPS

other side in group which is control group

Group Type NO_INTERVENTION

No interventions assigned to this group

Group i-PRF

group i-PRF: will include 9 patients receive i-PRF that will be performed on intervention sides according to a standardized protocol

Group Type EXPERIMENTAL

injectable platelet rich fibrin versus microosteoperforation

Intervention Type COMBINATION_PRODUCT

injectable platelet rich fibrin which is second product of blood versus microosteoperforation which is surgical procedure

group i-PRF2

other side in group which is control group

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

injectable platelet rich fibrin versus microosteoperforation

injectable platelet rich fibrin which is second product of blood versus microosteoperforation which is surgical procedure

Intervention Type COMBINATION_PRODUCT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. An age ranges from 15-22 years.
2. Severe crowding or protrusion requiring 1st premolars extractions followed by symmetrical canine retraction.
3. All permanent teeth present, 3rd molars are excluded.
4. Good oral and general health.
5. No systemic disease/medication that could interfere with OTM.
6. No previous orthodontic treatment.

Exclusion Criteria

1. Patient diagnosed to have an indication for non-extraction approach.
2. Poor oral hygiene or periodontally compromised patient.
3. Patient with craniofacial anomalies or previous history of trauma, bruxism or parafunctions.
4. Previous orthodontic treatment.

Minimum Eligible Age

15 Years

Maximum Eligible Age

22 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes